AREVA ( back to the Home Page )

Log in
This page allows you to manage all your electronic subscriptions on this site.
Register
Suscribe to the AREVA dashboard give you an access to newsletters, news, and email alerts from the Dialogue section...

Understanding radioimmunotherapy

decorative

Alpha radioimmunotherapy (alpha RIT) is a powerful anticancer therapy that targets cancerous cells without affecting the body’s healthy normal cells.

The potential of alpha radioimmunotherapy

Alpha RIT works by binding an isotope, such as 212Pb, to a monoclonal antibody.
Using the body’s own antigens, this treatment targets only cancer cells and destroys them.

It shows great promise for the treatment of numerous types of cancers, such as pancreatic, ovarian, melanoma, and others that do not respond efficiently to existing treatments.

How radioimmunotherapy works

Representation of the decay chain of 212 Bismuth
Business eNewsletter
Energy Business eNewsletter cover

Subscribe now to receive AREVA’s business eNewsletter!

Dialogue
  • Live dialogue
  • Ask your questions to our experts
AREVA locations throughout the world